Patrick Rosario, MD
General Practice · Monroeville, PANPI 1881609527
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,754 of the $7,486 with a category attached, or 63.5%. Abbott accounts for 67.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $3,152 and has fallen 93.2% since, to $213 in 2025. Among general practice clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $93.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Terumo Medical Corporation$1K
- Philips North America LLC$798
- Edwards Lifesciences$197
- Cardiovascular Systems Inc.$128
- Novo Nordisk$125
- plus $174 from 4 others
What the payments were for
- Travel & lodging$4,75464%
- Food & beverage$2,73236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $5,044 |
| Terumo Medical Corporation | 8 | $1,019 |
| Philips North America LLC | 22 | $798 |
| Edwards Lifesciences | 2 | $197 |
| Cardiovascular Systems Inc. | 4 | $128 |
| Novo Nordisk | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $119 |
| Smith+Nephew | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnilink Elite vascular stent system$1,474
- SUPERA$1,391
- Navicross$964
- PERCLOSE PROGLIDE$774
- IGT D Peripheral$563
- Glidesheath$229
- GlideWire$229
- ESPRIT$166
- JETI$148
- VOQUEZNA$119
How this compares
$7,486 in reported general payments places this provider in the 95th percentile of 3,208 general practice providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $18,411 |
| ClopidogrelClopidogrel Bisulfate | 114 | $1,158 |
| Nifedipine ErNifedipine | 15 | $686 |
| Ropinirole Hcl | 15 | $177 |
| Potassium Chloride | 20 | $159 |
| Furosemide | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other general practice in Monroeville
- Carl MedgausMonroeville$192K
- Rick RivardoMonroeville$9K
- Corey AnolikPhiladelphia$2.1M
- Richard NagelbergPlymouth Meeting$1.4M
- Alan AtlasPhiladelphia$486K
- Susan McMahonPittsburgh$364K
- Yooson KimMorgantown$166K
- Michael WollockArdmore$113K
- Marc ManosPhiladelphia$85K
- Michele ColumboBryn Mawr$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.